Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nasally Inhaled Isopropyl Alcohol Versus Oral Ondansetron for the Treatment of Nausea in the Emergency Department: A Double-Blind Randomized Controlled Trial

NCT02760069 is registered in ClinicalTrials.gov with Brooke Army Medical Center as lead sponsor.

NCT NCT02760069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02760069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nasally Inhaled Isopropyl Alcohol Versus Oral Ondansetron for the Treatment of Nausea in the Emergency Department: A Double-Blind Randomized Controlled Trial
Lead sponsor
Brooke Army Medical Center
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2016
Completion date
November 30, 2017
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nausea